Biomanufacturing robotics company Multiply Labs announced the completion of a $75 million Series B funding round led by NantWorks, with participation from AstraZeneca, Teradyne, Lingotto and existing investors, bringing total funding to over $100 million. The funds will be used to expand the team, accelerate automated production lines, and advance the platform from clinical projects to commercial-scale manufacturing.